HUP9801869A2 - Készítmény az L-karnitinszint megnövelésére emberben - Google Patents

Készítmény az L-karnitinszint megnövelésére emberben

Info

Publication number
HUP9801869A2
HUP9801869A2 HU9801869A HUP9801869A HUP9801869A2 HU P9801869 A2 HUP9801869 A2 HU P9801869A2 HU 9801869 A HU9801869 A HU 9801869A HU P9801869 A HUP9801869 A HU P9801869A HU P9801869 A2 HUP9801869 A2 HU P9801869A2
Authority
HU
Hungary
Prior art keywords
carnitin
pharmaceutical composition
human patients
enhancing level
enhancing
Prior art date
Application number
HU9801869A
Other languages
English (en)
Inventor
Mihály Szilágyi
Attila Sándor
Ágnes Vadász
Original Assignee
Mihály Szilágyi
Attila Sándor
Ágnes Vadász
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mihály Szilágyi, Attila Sándor, Ágnes Vadász filed Critical Mihály Szilágyi
Priority to HU9801869A priority Critical patent/HUP9801869A3/hu
Publication of HU9801869D0 publication Critical patent/HU9801869D0/hu
Publication of HUP9801869A2 publication Critical patent/HUP9801869A2/hu
Publication of HUP9801869A3 publication Critical patent/HUP9801869A3/hu

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya készítmény, különösen gyógyászati készítményés/vagy élelmiszer-kiegészítő az L-karnitinszint megnöveléséreemberben. A találmány szerinti készítmény hatóanyagként 4-(N,N,N-trimetil-ammóniűm)-bűtirátőt és adőtt esetben aszkőrbinsavat tartalmazkívánt esetben a szőkásős vivőanyag(ők) mellett. ŕ
HU9801869A 1998-08-13 1998-08-13 Pharmaceutical composition for enhancing level of l-carnitin in human patients HUP9801869A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9801869A HUP9801869A3 (en) 1998-08-13 1998-08-13 Pharmaceutical composition for enhancing level of l-carnitin in human patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9801869A HUP9801869A3 (en) 1998-08-13 1998-08-13 Pharmaceutical composition for enhancing level of l-carnitin in human patients

Publications (3)

Publication Number Publication Date
HU9801869D0 HU9801869D0 (en) 1998-10-28
HUP9801869A2 true HUP9801869A2 (hu) 2000-06-28
HUP9801869A3 HUP9801869A3 (en) 2000-07-28

Family

ID=89996953

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801869A HUP9801869A3 (en) 1998-08-13 1998-08-13 Pharmaceutical composition for enhancing level of l-carnitin in human patients

Country Status (1)

Country Link
HU (1) HUP9801869A3 (hu)

Also Published As

Publication number Publication date
HUP9801869A3 (en) 2000-07-28
HU9801869D0 (en) 1998-10-28

Similar Documents

Publication Publication Date Title
AP9801392A0 (en) Concentrated antibody preparation.
HK1010484A1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
EP0960107A4 (hu)
FR2790645B1 (fr) Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
IL183953A0 (en) Method of reducing oxidant induced damage of a food product, a pharmaceutical, or stored blood
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
TNSN96016A1 (fr) Utilisation de phenylcyclohexylcarboxamides
WO1999018941A3 (en) Ih-MODULATORS
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
HUP9801869A2 (hu) Készítmény az L-karnitinszint megnövelésére emberben
GB9505082D0 (en) Medicament
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
HK1050203A1 (en) Novel fusidic acid derivatives.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
EP0948961A3 (de) Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff
ZA981558B (en) Inclusion complexes in aqueous solution